{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:57:05Z","timestamp":1781240225625,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023A1515010242"],"award-info":[{"award-number":["2023A1515010242"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016966","name":"Bethune Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016966","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072384"],"award-info":[{"award-number":["82072384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52373135"],"award-info":[{"award-number":["52373135"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jconrel.2025.114200","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T23:00:00Z","timestamp":1757026800000},"page":"114200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Injectable PROTAC-loaded hydrogel remodels the tumor microenvironment to potentiate radio-immunotherapy"],"prefix":"10.1016","volume":"387","author":[{"given":"Weihe","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juehui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114200_bb0005","first-page":"34","article-title":"Magnetic resonance linear accelerator technology and adaptive radiation therapy: an overview for clinicians","volume":"72","author":"Hall","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2025.114200_bb0010","first-page":"1228","article-title":"Harnessing progress in radiotherapy for global cancer control","volume":"4","author":"Jaffray","year":"2023","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2025.114200_bb0015","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrclinonc.2016.79","article-title":"Clinical development of new drug\u2013radiotherapy combinations","volume":"13","author":"Sharma","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114200_bb0020","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41551-018-0203-4","article-title":"Low-dose X-ray radiotherapy\u2013radiodynamic therapy via nanoscale metal\u2013organic frameworks enhances checkpoint blockade immunotherapy","volume":"2","author":"Lu","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114200_bb0025","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114200_bb0030","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41575-019-0247-2","article-title":"Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers","volume":"17","author":"Buckley","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114200_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-022-02430-1","article-title":"Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death","volume":"41","author":"Bao","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114200_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202300204","article-title":"Biomaterials that induce immunogenic cell death","volume":"7","author":"Li","year":"2023","journal-title":"Small Methods"},{"key":"10.1016\/j.jconrel.2025.114200_bb0045","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/cells10040930","article-title":"Biomarkers of radiotherapy-induced immunogenic cell death","volume":"10","author":"Vaes","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2025.114200_bb0050","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2025.114200_bb0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114200_bb0060","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1021\/acs.chemrev.7b00258","article-title":"Nanotechnology for multimodal synergistic cancer therapy","volume":"117","author":"Fan","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.114200_bb0065","first-page":"681","article-title":"PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer","volume":"1","author":"Oh","year":"2020","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2025.114200_bb0070","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41416-023-02244-8","article-title":"Irradiation plus myeloid-derived suppressor cell-targeted therapy for overcoming treatment resistance in immunologically cold urothelial carcinoma","volume":"128","author":"Yamamoto","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114200_bb0075","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114200_bb0080","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.celrep.2017.11.095","article-title":"BET Bromodomain inhibition synergizes with PARP inhibitor in epithelial ovarian cancer","volume":"21","author":"Karakashev","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.114200_bb0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2019.10.011","article-title":"The combination of BET and PARP inhibitors is synergistic in models of cholangiocarcinoma","volume":"468","author":"Fehling","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2025.114200_bb0090","doi-asserted-by":"crossref","first-page":"eaal1645","DOI":"10.1126\/scitranslmed.aal1645","article-title":"Repression of BET activity sensitizes homologousrecombination\u2013proficient cancers to PARP inhibition","volume":"9","author":"Yang","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114200_bb0095","article-title":"PROTAC prodrug-integrated nanosensitizer for potentiating radiation therapy of cancer","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114200_bb0100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ebiom.2019.05.035","article-title":"The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitors","volume":"44","author":"Miller","year":"2019","journal-title":"eBioMedicine"},{"key":"10.1016\/j.jconrel.2025.114200_bb0105","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.ymthe.2021.05.019","article-title":"BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma","volume":"29","author":"Xia","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114200_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-022-01561-z","article-title":"Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment","volume":"20","author":"Gu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114200_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101661","article-title":"In-situ clickable prodrug nanoplatform locally activates T lymphocytes to potentiate cancer immunotherapy","volume":"47","author":"Hou","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.114200_bb0120","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1016\/j.ymthe.2022.07.022","article-title":"BET inhibition triggers antitumor immunity by enhancing MHC class I expression in head and neck squamous cell carcinoma","volume":"30","author":"Zhang","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114200_bb0125","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mattod.2023.06.024","article-title":"Orchestrated copper-based nanoreactor for remodeling tumor microenvironment to amplify cuproptosis-mediated anti-tumor immunity in colorectal cancer","volume":"68","author":"Jin","year":"2023","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2025.114200_bb0130","article-title":"Chemotherapy-enabled colorectal cancer immunotherapy of self-delivery nano-PROTACs by inhibiting tumor glycolysis and avoiding adaptive immune resistance","volume":"11","author":"Zhao","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.114200_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2024.110067","article-title":"Injectable hydrogel-based tumor vaccine with fibrotic tumor immune microenvironment remodeling to prevent breast cancer postoperative recurrence and metastases","volume":"36","author":"Sun","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2025.114200_bb0140","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/j.celrep.2016.08.032","article-title":"BET Bromodomain inhibition promotes anti-tumor immunity by suppressing PD-L1 expression","volume":"16","author":"Zhu","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.114200_bb0145","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.celrep.2017.02.011","article-title":"BET-Bromodomain inhibitors engage the host immune system and regulate expression of the immune checkpoint ligand PD-L1","volume":"18","author":"Hogg","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.114200_bb0150","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature13229","article-title":"Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer","volume":"510","author":"Asangani","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114200_bb0155","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/nm.4378","article-title":"Prostate cancer\u2013associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4","volume":"23","author":"Dai","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114200_bb0160","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02615-2","article-title":"The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma","volume":"42","author":"Feng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114200_bb0165","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.chembiol.2015.05.009","article-title":"Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4","volume":"22","author":"Lu","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jconrel.2025.114200_bb0170","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114200_bb0175","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41589-019-0362-y","article-title":"Development of targeted protein degradation therapeutics","volume":"15","author":"Chamberlain","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2025.114200_bb0180","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41573-019-0047-y","article-title":"Targeted protein degradation: expanding the toolbox","volume":"18","author":"Schapira","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114200_bb0185","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114200_bb0190","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","article-title":"PROTACs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.114200_bb0195","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.chembiol.2020.07.020","article-title":"PROTACs: an emerging therapeutic modality in precision medicine","volume":"27","author":"Nalawansha","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jconrel.2025.114200_bb0200","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1021\/acs.jmedchem.8b01826","article-title":"Highly selective PTK2 Proteolysis targeting chimeras to probe focal adhesion kinase scaffolding functions","volume":"62","author":"Popow","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.114200_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030611","article-title":"Synthesis and biological activity of a VHL-based PROTAC specific for p38\u03b1","volume":"15","author":"Cubillos-Rojas","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2025.114200_bb0210","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/s41375-019-0440-x","article-title":"Degradation of Bruton\u2019s tyrosine kinase mutants by PROTACs for potential treatment of ibrutinib-resistant non-Hodgkin lymphomas","volume":"33","author":"Sun","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2025.114200_bb0215","article-title":"DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance","volume":"15","author":"Schr\u00f6der","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114200_bb0220","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.1021\/jacs.1c03852","article-title":"TF-PROTACs enable targeted degradation of transcription factors","volume":"143","author":"Liu","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.114200_bb0225","article-title":"Destruction of DNA-binding proteins by programmable oligonucleotide PROTAC (O\u2019PROTAC): effective targeting of LEF1 and ERG","volume":"8","author":"Shao","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.114200_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.672267","article-title":"From conception to development: investigating PROTACs features for improved cell permeability and successful protein degradation","volume":"9","author":"Cecchini","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.jconrel.2025.114200_bb0235","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.scib.2023.04.028","article-title":"Stimuli-activatable PROTACs for precise protein degradation and cancer therapy","volume":"68","author":"Gao","year":"2023","journal-title":"Sci. Bull."},{"key":"10.1016\/j.jconrel.2025.114200_bb0240","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1039\/D1CS00762A","article-title":"Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation","volume":"51","author":"Chen","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.114200_bb0245","doi-asserted-by":"crossref","first-page":"8741","DOI":"10.1021\/acs.nanolett.4c02287","article-title":"Ultrasound-activated PROTAC prodrugs overcome immunosuppression to actuate efficient deep-tissue sono-immunotherapy in orthotopic pancreatic tumor mouse models","volume":"24","author":"Liu","year":"2024","journal-title":"Nano Lett."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:07:54Z","timestamp":1780477674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925008120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":49,"alternative-id":["S0168365925008120"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114200","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Injectable PROTAC-loaded hydrogel remodels the tumor microenvironment to potentiate radio-immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114200"}}